MARKET

LQDA

LQDA

Liquidia Corporation
NASDAQ
34.49
+0.06
+0.17%
After Hours: 34.48 -0.01 -0.03% 19:32 12/31 EST
OPEN
34.13
PREV CLOSE
34.43
HIGH
35.20
LOW
33.92
VOLUME
945.07K
TURNOVER
--
52 WEEK HIGH
36.41
52 WEEK LOW
11.26
MARKET CAP
3.00B
P/E (TTM)
-24.1121
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LQDA last week (1222-1226)?
Weekly Report · 12/29/2025 09:12
Liquidia Price Target Maintained With a $49.00/Share by BTIG
Dow Jones · 12/26/2025 17:57
BTIG Reiterates Buy on Liquidia, Maintains $49 Price Target
Benzinga · 12/26/2025 17:47
Liquidia Technologies call volume above normal and directionally bullish
TipRanks · 12/23/2025 18:25
Regencell Bioscience is the top performing pharma stock YTD
Seeking Alpha · 12/23/2025 04:47
Weekly Report: what happened at LQDA last week (1215-1219)?
Weekly Report · 12/22/2025 09:12
Wells Fargo Remains a Buy on Liquidia Technologies (LQDA)
TipRanks · 12/18/2025 16:16
Liquidia’s Phase 3 Study: Pioneering Treatment for Pulmonary Hypertension
TipRanks · 12/17/2025 16:32
More
About LQDA
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The Company operate through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enable precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is an inhaled dry powder formulation of treprostinil designed with PRINT to improve the therapeutic profile of treprostinil by enhancing deep lung delivery while using a convenient, dry-powder inhaler (DPI) and by achieving higher dose levels than the labeled doses of current inhaled therapies.

Webull offers Liquidia Corp stock information, including NASDAQ: LQDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LQDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LQDA stock methods without spending real money on the virtual paper trading platform.